Document_And_Entity_Informatio
Document And Entity Information | 9 Months Ended | |
Sep. 28, 2013 | Oct. 30, 2013 | |
Document and Entity Information [Abstract] | ' | ' |
Entity Registrant Name | 'RCM TECHNOLOGIES INC | ' |
Document Type | '10-Q | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Common Stock, Shares Outstanding | ' | 12,366,959 |
Amendment Flag | 'false | ' |
Entity Central Index Key | '0000700841 | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Voluntary Filers | 'No | ' |
Entity Filer Category | 'Smaller Reporting Company | ' |
Entity Well-known Seasoned Issuer | 'No | ' |
Document Period End Date | 28-Sep-13 | ' |
Document Fiscal Year Focus | '2013 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Condsolidated_Balance_Sheet_Cu
Condsolidated Balance Sheet (Current Period Unaudited) (USD $) | Sep. 28, 2013 | Dec. 29, 2012 |
In Thousands, unless otherwise specified | ||
Cash and cash equivalents | $14,049 | $14,123 |
Accounts receivable, net | 54,828 | 43,706 |
Transit accounts receivable | 5,374 | 10,010 |
Prepaid expenses and other current assets | 1,244 | 1,965 |
Deferred income tax assets, domestic | 485 | 541 |
Total current assets | 75,980 | 70,345 |
Property and equipment, net | 2,219 | 1,880 |
Deposits | 203 | 244 |
Goodwill | 9,545 | 9,545 |
Intangible assets, net | 236 | 332 |
Deferred income tax assets, domestic | 1,773 | 2,202 |
Total other assets | 11,757 | 12,323 |
Total assets | 89,956 | 84,548 |
Accounts payable and accrued expenses | 11,374 | 6,334 |
Transit accounts payable | 5,808 | 11,987 |
Accrued payroll and related costs | 7,951 | 6,241 |
Income taxes payable | 1,006 | 119 |
Deferred income tax liability, foreign | 102 | 73 |
Contingent consideration | 313 | 309 |
Total current liabilities | 26,554 | 25,063 |
Contingent consideration | 617 | 713 |
Total liabilities | 27,171 | 25,776 |
Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding | 0 | 0 |
Common stock, $0.05 par value; 40,000,000 shares authorized; 13,839,265 shares issued and 12,365,959 shares outstanding at September 28, 2013 and 13,756,589 shares issued and 12,298,733 shares outstanding at December 29, 2012 | 692 | 688 |
Additional paid-in capital | 110,258 | 109,390 |
Accumulated other comprehensive income | 1,022 | 1,370 |
Accumulated deficit | -41,687 | -45,259 |
Treasury stock common (1,473,306 shares at September 28, 2013 and 1,457,856 at December 29, 2012, at cost) | -7,500 | -7,417 |
Stockholders’ equity | 62,785 | 58,772 |
Total liabilities and stockholders’ equity | $89,956 | $84,548 |
Condsolidated_Balance_Sheet_Cu1
Condsolidated Balance Sheet (Current Period Unaudited) (Parentheticals) (USD $) | Sep. 28, 2013 | Dec. 29, 2012 |
Preferred stock par value (in Dollars per share) | $1 | $1 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in Dollars per share) | $0.05 | $0.05 |
Common stock, shares authorized | 40,000,000 | 40,000,000 |
Common stock, shares issued | 13,839,265 | 13,756,589 |
Common stock, shares outstanding | 12,365,959 | 12,298,733 |
Treasury stock shares | 1,473,306 | 1,457,856 |
Consolidated_Statements_of_Inc
Consolidated Statements of Income (Unaudited) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 | Sep. 28, 2013 | Sep. 29, 2012 |
Revenues | $41,320 | $34,839 | $124,929 | $108,798 |
Cost of services | 30,636 | 25,164 | 92,362 | 79,182 |
Gross profit | 10,684 | 9,675 | 32,567 | 29,616 |
Selling, general and administrative | 8,599 | 8,153 | 26,361 | 24,766 |
Facilities consolidation charge | ' | ' | 343 | ' |
Depreciation and amortization | 279 | 415 | 829 | 953 |
8,878 | 8,568 | 27,533 | 25,719 | |
Operating income | 1,806 | 1,107 | 5,034 | 3,897 |
Interest expense and other, net | -14 | -11 | -36 | -32 |
Reduction in contingent consideration | ' | ' | 92 | 43 |
Gain on foreign currency transactions | 10 | -1 | 18 | 7 |
-4 | -12 | 74 | 18 | |
Income before income taxes | 1,802 | 1,095 | 5,108 | 3,915 |
Income tax expense | 660 | 461 | 1,536 | 1,718 |
Net income | $1,142 | $634 | $3,572 | $2,197 |
Basic net earnings per share (in Dollars per share) | $0.09 | $0.05 | $0.29 | $0.18 |
Diluted net earnings per share (in Dollars per share) | $0.09 | $0.05 | $0.29 | $0.17 |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (Unaudited) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 |
Net income | $3,572 | $2,197 |
Foreign currency translation adjustment | -348 | 110 |
Comprehensive income | $3,224 | $2,307 |
Consolidated_Statements_of_Cha
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (USD $) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Other Comprehensive Income (Loss) [Member] | Accumulated Deficit [Member] | Treasury Stock [Member] | Total |
Balance at Dec. 29, 2012 | $688,000 | $109,390,000 | $1,370,000 | ($45,259,000) | ($7,417,000) | $58,772,000 |
Balance (in Shares) at Dec. 29, 2012 | 13,756,589 | ' | ' | ' | 1,457,856 | ' |
Issuance of stock under employee stock purchase plan | 3,000 | 256,000 | ' | ' | ' | 259,000 |
Issuance of stock under employee stock purchase plan (in Shares) | 58,176 | ' | ' | ' | ' | ' |
Translation adjustment | ' | ' | -348,000 | ' | ' | -348,000 |
Issuance of stock upon exercise of stock options | 1,000 | 97,000 | ' | ' | ' | 98,000 |
Issuance of stock upon exercise of stock options (in Shares) | 24,500 | ' | ' | ' | ' | -24,500 |
Share-based compensation expense | ' | 515,000 | ' | ' | ' | 515,000 |
Common stock repurchase | ' | ' | ' | ' | -83,000 | -83,000 |
Common stock repurchase (in Shares) | ' | ' | ' | ' | 15,450 | ' |
Net income | ' | ' | ' | 3,572,000 | ' | 3,572,000 |
Balance at Sep. 28, 2013 | $692,000 | $110,258,000 | $1,022,000 | ($41,687,000) | ($7,500,000) | $62,785,000 |
Balance (in Shares) at Sep. 28, 2013 | 13,839,265 | ' | ' | ' | 1,473,306 | ' |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (Unaudited) (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 |
Net income | $3,572 | $2,197 |
Depreciation and amortization | 829 | 953 |
Changes in fair value of contingent consideration | -92 | -43 |
Stock-based compensation expense | 515 | 60 |
Provision for allowance for doubtful accounts | -519 | 353 |
Deferred income tax expense | 518 | 430 |
Accounts receivable | -11,055 | 891 |
Transit accounts receivable | 4,641 | -304 |
Prepaid expenses and other current assets | 682 | 170 |
Accounts payable and accrued expenses | 5,178 | -227 |
Transit accounts payable | -6,180 | 881 |
Accrued payroll and related costs | 1,764 | 1,854 |
Income taxes payable | 887 | 233 |
Total adjustments | -2,832 | 5,251 |
Net cash provided by operating activities | 740 | 7,448 |
Property and equipment acquired | -1,071 | -250 |
Decrease (increase) in deposits | 41 | -109 |
Cash paid for acquisition | ' | -1,292 |
Net cash used in investing activities | -1,030 | -1,651 |
Sale of stock for employee stock purchase plan | 259 | 128 |
Exercise of stock options | 98 | 314 |
Common stock repurchases | -83 | -4,425 |
Net cash provided by (used in) financing activities | 274 | -3,983 |
Effect of exchange rate changes on cash and cash equivalents | -58 | -19 |
(Decrease) increase in cash and cash equivalents | -74 | 1,795 |
Cash and cash equivalents at beginning of period | 14,123 | 28,417 |
Cash and cash equivalents at end of period | 14,049 | 30,212 |
Interest | 46 | 35 |
Income taxes | $250 | $1,616 |
Note_1_Basis_of_Presentation
Note 1 - Basis of Presentation | 9 Months Ended |
Sep. 28, 2013 | |
Disclosure Text Block [Abstract] | ' |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | ' |
1. Basis of Presentation | |
The accompanying consolidated interim financial statements of RCM Technologies, Inc. and subsidiaries (“RCM” or the “Company”) are unaudited. The year-end consolidated balance sheet was derived from audited statements but does not include all disclosures required by accounting principles generally accepted in the United States. These statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission pertaining to reports on Form 10-Q and should be read in conjunction with the Company’s consolidated financial statements and the notes thereto for the year ended December 29, 2012 included in the Company’s Annual Report Form 10-K for such period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. | |
The consolidated financial statements for the unaudited interim periods presented include all adjustments (consisting only of normal, recurring adjustments except for the reduction of the contingent consideration pertaining to the PSG acquisition) necessary for a fair presentation of financial position, results of operations and cash flows for such interim periods. | |
Results for the thirteen and thirty-nine week periods ended September 28, 2013 are not necessarily indicative of results that may be expected for the full year. |
Note_2_Fiscal_Year
Note 2 - Fiscal Year | 9 Months Ended | ||
Sep. 28, 2013 | |||
Disclosure Text Block [Abstract] | ' | ||
Business Description and Basis of Presentation [Text Block] | ' | ||
2. Fiscal Year | |||
The Company follows a 52/53 week fiscal reporting calendar ending on the Saturday closest to December 31. The fiscal year ended December 29, 2012 was a 52-week reporting year. The third fiscal quarters of 2013 and 2012 ended on the following dates, respectively: | |||
Period Ended | Weeks in Quarter | Weeks in Year to Date | |
28-Sep-13 | Thirteen | Thirty-Nine | |
29-Sep-12 | Thirteen | Thirty-Nine | |
Note_3_Use_of_Estimates_and_Un
Note 3 - Use of Estimates and Uncertainties | 9 Months Ended |
Sep. 28, 2013 | |
Disclosure Text Block [Abstract] | ' |
Basis of Presentation and Significant Accounting Policies [Text Block] | ' |
3. Use of Estimates and Uncertainties | |
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and disclosure of contingent assets and liabilities. Actual results could differ from those estimates. | |
The Company uses estimates to calculate an allowance for doubtful accounts on its accounts receivables, adequacy of reserves, the tax rate applied and the valuation of certain assets and liability accounts. These estimates can be significant to the operating results and financial position of the Company. | |
The Company has risk participation arrangements with respect to workers compensation and health care insurance. The amounts included in the Company’s costs related to this risk participation are estimated and can vary based on changes in assumptions, the Company’s claims experience or the providers included in the associated insurance programs. | |
The Company can be affected by a variety of factors including uncertainty relating to the performance of the general economy, competition, demand for the Company’s services, adverse litigation and claims and the hiring, training and retention of key employees. | |
Fair Value of Financial Instruments | |
The Company’s carrying value of financial instruments, consisting primarily of accounts receivable, accounts payable and accrued expenses, approximates fair value due to their liquidity or their short-term nature. The Company does not have derivative products in place to manage risks related to foreign currency fluctuations for its foreign operations or for interest rate changes. |
Note_4_Accounts_Receivable
Note 4 - Accounts Receivable | 9 Months Ended | ||||||||
Sep. 28, 2013 | |||||||||
Receivables [Abstract] | ' | ||||||||
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | ' | ||||||||
4. Accounts Receivable | |||||||||
The Company’s accounts receivable are comprised as follows: | |||||||||
September 28, | December 29, | ||||||||
2013 | 2012 | ||||||||
Billed | $ | 36,131 | $ | 26,600 | |||||
Accrued and unbilled | 5,839 | 4,761 | |||||||
Work-in-progress | 13,836 | 13,552 | |||||||
Allowance for doubtful accounts and sales discounts | (978 | ) | (1,207 | ) | |||||
Accounts receivable, net | $ | 54,828 | $ | 43,706 | |||||
Unbilled receivables primarily represent revenues earned whereby those services are ready to be billed as of the balance sheet ending date. Work-in-process primarily represents revenues earned under contracts which the Company contractually invoices at future dates. |
Note_5_Property_and_Equipment
Note 5 - Property and Equipment | 9 Months Ended | ||||||||
Sep. 28, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, Plant and Equipment Disclosure [Text Block] | ' | ||||||||
5. Property and Equipment | |||||||||
Property and equipment are stated at cost and are depreciated on the straight-line method at rates calculated to provide for retirement of assets at the end of their estimated useful lives. The annual rates are 20% for computer hardware and software as well as furniture and office equipment. Leasehold improvements are amortized over the shorter of the estimated life of the asset or the lease term. | |||||||||
Property and equipment are comprised of the following: | |||||||||
September 28, | December 29, | ||||||||
2013 | 2012 | ||||||||
Equipment and furniture | $ | 2,380 | $ | 2,366 | |||||
Computers and systems | 5,582 | 5,204 | |||||||
Leasehold improvements | 480 | 949 | |||||||
8,442 | 8,519 | ||||||||
Less: accumulated depreciation and amortization | 6,223 | 6,639 | |||||||
Property and equipment, net | $ | 2,219 | $ | 1,880 | |||||
The Company periodically writes off fully depreciated assets. The Company wrote off fully depreciated assets of $1,149 and $1,466 for the thirty-nine week periods ended September 28, 2013 and September 29, 2012, respectively. |
Note_6_Acquisitions
Note 6 - Acquisitions | 9 Months Ended | ||||
Sep. 28, 2013 | |||||
Business Combinations [Abstract] | ' | ||||
Business Combination Disclosure [Text Block] | ' | ||||
6. Acquisitions | |||||
The Company has acquired numerous companies throughout its history and those acquisitions have generally included significant future contingent consideration. | |||||
Future Contingent Payments | |||||
As of September 28, 2013, the Company had one active acquisition agreement whereby additional contingent consideration may be earned. Effective July 1, 2012 the Company acquired certain assets of BGA, LLC (“BGA”) as more fully described below. The Company estimates future contingent payments at September 28, 2013 as follows: | |||||
Period Ending | |||||
28-Dec-13 | $ | 313 | |||
3-Jan-15 | 253 | ||||
2-Jan-16 | 269 | ||||
31-Dec-16 | 307 | ||||
Estimated future contingent consideration payments | $ | 1,142 | |||
Actual future contingent payments may materially differ from the estimates above. Future contingent payments to be made to BGA are capped at a maximum of $3.0 million cumulatively. The Company estimates future contingent consideration in payments based on forecasted performance and recorded the net present value of those expected payments as of September 28, 2013. The measurement is based on significant inputs that are not observable in the market, which “Fair Value Measurements and Disclosures” (ASU Topic 820-10-35) refers to as Level 3 inputs. | |||||
During the thirty-nine week period ended September 28, 2013, the Company reduced its liability for contingent consideration by $92, which eliminates any remaining accrual for contingent consideration related to the 2009 acquisition of certain assets of Project Solutions Group, Inc. The reduction is reflected in other income. There were no other changes to the fair value of the contingent consideration during the thirty-nine week period ended September 28, 2013. The Company paid no consideration during the thirty-nine week period ended September 28, 2013 or the comparable prior year period. | |||||
BGA, LLC | |||||
Effective July 1, 2012, the Company purchased the operating assets of BGA. BGA provides comprehensive multidiscipline engineering solutions across numerous industry sectors including Power Generation (both Nuclear and Fossil), Energy Delivery, Energy Management, Architecture, Commercial Building and Manufacturing. The Company believes that the BGA assembled workforce consists of highly trained and experienced engineers who will greatly assist RCM in executing future growth in revenues. The business acquired in the BGA acquisition will operate as part of the Company’s Engineering segment. The BGA purchase consideration consisted of the following: | |||||
Cash | $ | 1,292 | |||
Lease in excess of market, at fair value | 469 | ||||
Contingent consideration, at fair value | 930 | ||||
Total consideration | $ | 2,691 | |||
The acquisition has been accounted for under the purchase method of accounting. The total estimated purchase price has been allocated as follows: | |||||
Fixed assets | $ | 28 | |||
Restricted covenants | 70 | ||||
Customer relationships | 180 | ||||
Deferred tax asset | 187 | ||||
Goodwill | 2,226 | ||||
Total consideration | $ | 2,691 | |||
Fixed assets acquired were recorded at approximate market value. The values of restricted covenants and customer relationships were recorded based on the valuation of a third party firm. The primary item that generated goodwill was the acquisition of a highly skilled and trained assembled workforce of engineers that the Company anticipates may allow it to win contract awards from its current and future customer base that the Company would not otherwise win. | |||||
Pro Forma Results of Operations | |||||
The following (unaudited) results of operations have been prepared assuming the BGA acquisition had occurred | |||||
as of the beginning of the thirty-nine week period ended September 29, 2012. Those results are not necessarily indicative of results of future operations or of results that would have occurred had the acquisition occurred as of the beginning of the periods presented. | |||||
Proforma Results | |||||
for the Thirty-Nine | |||||
Week Period Ended | |||||
29-Sep-12 | |||||
Revenues | $ | 111,401 | |||
Operating income | 4,032 | ||||
Basic and diluted earnings per share | $ | 0.18 | |||
Note_7_Goodwill
Note 7 - Goodwill | 9 Months Ended |
Sep. 28, 2013 | |
Disclosure Text Block Supplement [Abstract] | ' |
Goodwill Disclosure [Text Block] | ' |
7. Goodwill | |
Goodwill represents the premium paid over the fair value of the net tangible and intangible assets acquired in business combinations. The Company is required to assess the carrying value of its reporting units that contain goodwill at least on an annual basis. The Company has the option to first assess qualitative factors to determine whether it is necessary to perform a two-step impairment test. If the Company believes, as a result of the qualitative assessment, that it is more likely than not that the fair value of a reporting unit is less than the carrying value, the quantitative impairment test is required. The Company formally assesses these qualitative factors, and if necessary, conducts its annual goodwill impairment test as of the last day of the Company’s fiscal November each year or if indicators of impairment exist. The Company has determined that the qualitative factors that exist do not suggest that an impairment of goodwill exists. | |
The carrying amount of goodwill at both September 28, 2013 and December 29, 2012 for the Company’s Information Technology, Engineering and Specialty Health Care segments was $5,516, $2,326 and $1,703, respectively. |
Note_8_Intangible_Assets
Note 8 - Intangible Assets | 9 Months Ended | ||||||||||||
Sep. 28, 2013 | |||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||
Intangible Assets Disclosure [Text Block] | ' | ||||||||||||
8. Intangible Assets | |||||||||||||
The Company evaluates long-lived assets and intangible assets with definite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When the Company determines that it is probable that undiscounted future cash flows will not be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value. Assets to be disposed of by sale, if any, are reported at the lower of the carrying amount or fair value less cost to sell. The Company’s intangible assets consist of customer relationships and non-compete agreements. | |||||||||||||
The following table reflects the components of net intangible assets, excluding goodwill: | |||||||||||||
Information Technology | Engineering | Total | |||||||||||
Balance as of December 29, 2012 | $ | 106 | $ | 226 | $ | 332 | |||||||
Amortization of intangibles during the thirty-nine week period ended September 28, 2013 | 60 | 36 | 96 | ||||||||||
Balance as of September 28, 2013 | $ | 46 | $ | 190 | $ | 236 | |||||||
The Company periodically writes off fully amortized intangible assets. The Company did not write off any fully amortized intangibles for the thirty-nine week period ended September 28, 2013 and wrote off fully amortized intangibles of $171 for the thirty-nine week period ended September 29, 2012. |
Note_9_Line_of_Credit
Note 9 - Line of Credit | 9 Months Ended |
Sep. 28, 2013 | |
Disclosure Text Block [Abstract] | ' |
Short-term Debt [Text Block] | ' |
9. Line of Credit | |
The Company and its subsidiaries are party to a loan agreement with Citizens Bank of Pennsylvania, amended and restated effective February 20, 2009, which provides for a $15 million revolving credit facility and includes a sub-limit of $5 million for letters of credit (the “Revolving Credit Facility”). The Revolving Credit Facility has been amended several times, most recently on December 24, 2011 when the maturity date was extended to August 31, 2016. Borrowings under the Revolving Credit Facility bear interest at one of two alternative rates, as selected by the Company at each incremental borrowing. These alternatives are: (i) LIBOR (London Interbank Offered Rate), plus applicable margin, or (ii) the agent bank’s prime rate. The Company also pays unused line fees based on the amount of the Revolving Credit Facility that is not drawn. Unused line fees are recorded as interest expense. | |
All borrowings under the Revolving Credit Facility are collateralized by all of the assets of the Company and its subsidiaries and a pledge of the stock of its subsidiaries. The Revolving Credit Facility also contains various financial and non-financial covenants, such as restrictions on the Company’s ability to borrow to pay dividends. | |
There were no borrowings during the thirty-nine week periods ended September 28, 2013 and September 29, 2012. At both September 28, 2013 and December 29, 2012, there were letters of credit outstanding for $0.8 million. At September 28, 2013, the Company had availability for additional borrowings under the Revolving Credit Facility of $14.2 million. |
Note_10_Per_Share_Data
Note 10 - Per Share Data | 9 Months Ended | ||||||||||||||||
Sep. 28, 2013 | |||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||
Earnings Per Share [Text Block] | ' | ||||||||||||||||
10. Per Share Data | |||||||||||||||||
Both basic and diluted earnings per share for all periods are calculated based on the reported earnings in the Company’s consolidated statements of income. | |||||||||||||||||
The number of shares of common stock used to calculate basic and diluted earnings per share for the thirteen and thirty-nine week periods ended September 28, 2013 and September 29, 2012 was determined as follows: | |||||||||||||||||
Thirteen Week Periods Ended | Thirty-Nine Week Periods Ended | ||||||||||||||||
September 28, | September 29, | September 28, | September 29, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Basic weighted average shares outstanding | 12,364,018 | 12,057,478 | 12,333,318 | 12,422,558 | |||||||||||||
Dilutive effect of outstanding stock options | 123,400 | 194,731 | 98,143 | 205,140 | |||||||||||||
Weighted average dilutive shares outstanding | 12,487,418 | 12,252,209 | 12,431,461 | 12,627,698 | |||||||||||||
There were 97,500 and 62,500 absolute anti-dilutive shares not included in the calculation of common stock equivalents for the thirty-nine week periods ended September 28, 2013 and September 29, 2012, respectively. These were determined to be anti-dilutive because the exercise prices of these shares for the period were higher than the average price of all shares for the same period. | |||||||||||||||||
Unissued shares of common stock were reserved for the following purposes: | |||||||||||||||||
September 28, | December 29, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
Exercise of options outstanding | 279,900 | 307,400 | |||||||||||||||
Restricted stock awards outstanding | 327,500 | 350,000 | |||||||||||||||
Future grants of options or shares | 56,600 | 34,100 | |||||||||||||||
Shares reserved for employee stock purchase plan | 189,576 | 247,752 | |||||||||||||||
Total | 853,576 | 939,252 | |||||||||||||||
Note_11_Share_Based_Compensati
Note 11 - Share Based Compensation | 9 Months Ended | |||||||||
Sep. 28, 2013 | ||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | ' | |||||||||
11. Share-Based Compensation | ||||||||||
At September 28, 2013, the Company had three share-based employee compensation plans. The Company measures the fair value of share-based awards, if and when granted, based on the Black-Scholes method and using the closing market price of the Company’s common stock on the date of grant. Awards vest over periods ranging from one to three years and expire within 10 years of issuance. Share-based compensation expense related to awards is amortized in accordance with applicable vesting periods using the straight-line method. Share-based compensation expense of $515 and $60 was recognized for the thirty-nine week periods ended September 28, 2013 and September 29, 2012, respectively. | ||||||||||
As of September 28, 2013, the Company had approximately $1.2 million of total unrecognized compensation cost related to all non-vested share-based awards granted under the Company’s various share-based plans, which the Company expects to recognize over approximately a three-year period. These amounts do not include the cost of any additional share-based awards that may be granted in future periods or reflect any potential changes in the Company’s forfeiture rate. | ||||||||||
Incentive Share-Based Plans | ||||||||||
1996 Executive Stock Option Plan (the 1996 Plan) | ||||||||||
The 1996 Plan, approved by the Company’s stockholders in August 1996 and amended in April 1999, provided for the issuance of up to 1,250,000 shares of the Company’s common stock to officers and key employees of the Company and its subsidiaries through January 1, 2006, at which time the 1996 Plan expired. Options were generally granted at fair market value at the date of grant. The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. As of September 28, 2013, options to purchase 132,000 shares of common stock granted under the 1996 Plan were outstanding. | ||||||||||
2000 Employee Stock Incentive Plan (the 2000 Plan) | ||||||||||
The 2000 Plan, approved by the Company’s stockholders in April 2001, provided for the issuance of up to 1,500,000 shares of the Company’s common stock to officers and key employees of the Company and its subsidiaries or consultants and advisors utilized by the Company. The Compensation Committee of the Board of Directors may award incentive stock options or non-qualified stock options, as well as stock appreciation rights, and determines the vesting period at the time of grant. As of September 28, 2013, options to purchase 71,500 shares of common stock granted under the 2000 Plan were outstanding. | ||||||||||
The 1996 Plan and 2000 Plan are expired and therefore no shares are available for grant thereunder. | ||||||||||
2007 Omnibus Equity Compensation Plan (the 2007 Plan) | ||||||||||
The 2007 Plan, approved by the Company’s stockholders in June 2007, provides for the issuance of up to 700,000 shares of the Company’s common stock to officers, non-employee directors, employees of the Company and its subsidiaries or consultants and advisors utilized by the Company. No more than 350,000 shares of common stock in the aggregate may be issued pursuant to grants of stock awards, stock units, performance shares and other stock-based awards. No more than 300,000 shares of common stock with respect to awards may be granted to any individual during any fiscal year. The Compensation Committee of the Board of Directors determines the vesting period at the time of grant. As of September 28, 2013, under the 2007 Plan, 56,600 shares of common stock were available for future grants and options to purchase 76,400 shares of common stock, as well as 327,500 restricted stock units, were outstanding. | ||||||||||
Stock Options | ||||||||||
There were 5,000 options granted during the thirty-nine week period ended September 28, 2013 and 20,000 options granted during the thirty-nine week period ended September 29, 2012. Activity regarding outstanding options for the thirty-nine week period ended September 28, 2013 is as follows: | ||||||||||
All Stock Options Outstanding | ||||||||||
Shares | Weighted Average | |||||||||
Exercise Price | ||||||||||
Options outstanding as of December 29, 2012 | 307,400 | $ | 5.34 | |||||||
Options granted | 5,000 | $ | 5.78 | |||||||
Options exercised | -24,500 | $ | 4.01 | |||||||
Options forfeited/cancelled | -8,000 | $ | 5.16 | |||||||
Options outstanding as of September 28, 2013 | 279,900 | $ | 5.47 | |||||||
Options outstanding price range at September 28, 2013 | $2.50 | - | $9.81 | |||||||
Options exercisable as of September 28, 2013 | 224,900 | $ | 5.44 | |||||||
Intrinsic value of outstanding stock options as of September 28, 2013 | $290 | |||||||||
Intrinsic value of stock options exercised for the thirty-nine week period ended September 28, 2013 | $40 | |||||||||
As of September 28, 2013, the Company had approximately $0.1 million of total unrecognized compensation cost related to non-vested stock option awards granted under the Company’s various share-based plans, which the Company expects to recognize over approximately a three-year period. These amounts do not include the cost of any additional options that may be granted in future periods or reflect any potential changes in the Company’s forfeiture rate. | ||||||||||
Restricted Stock Units | ||||||||||
On November 16, 2012, the Company granted 350,000 restricted stock units all of which fully vest after three years of continued service. All of these restricted stock units include dividend accrual equivalents, which means that any dividends paid by the Company during the three year vesting period become due and payable after the three year vesting period assuming the grantee’s restricted stock unit fully vests. Dividends for these grants are accrued on the dividend payment dates and included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. Dividends for restricted share units that ultimately do not vest are forfeited. | ||||||||||
To date, the Company has only issued restricted stock units under the 2007 Plan. The following summarizes the restricted stock units activity under the 2007 Plan during 2013: | ||||||||||
Number of | Weighted | |||||||||
Restricted | Average | |||||||||
Stock Units | Grant Date Fair | |||||||||
(in thousands) | Value per Share | |||||||||
Outstanding non-vested at December 29, 2012 | 350 | $ | 5.62 | |||||||
Granted | 8 | $ | 5.45 | |||||||
Vested | - | N/A | ||||||||
Forfeited or expired | (30 | ) | $ | 5.62 | ||||||
Outstanding non-vested at September 28, 2013 | 328 | $ | 5.62 | |||||||
Based on the closing price of the Company’s common stock of $6.04 per share on September 28, 2013, the intrinsic value of the non-vested restricted stock units at September 28, 2013 was approximately $2.0 million. As of September 28, 2013, there was approximately $1.1 million of total unrecognized compensation cost related to restricted stock units, which is expected to be recognized over a weighted-average period of approximately 25.5 months. | ||||||||||
Employee Stock Purchase Plan | ||||||||||
The Company implemented the 2001 Employee Stock Purchase Plan with stockholder approval, effective January 1, 2001. Such Plan was subsequently amended, pursuant to stockholder approval where required, effective June 18, 2009 and September 16, 2009 (the 2001 Employee Stock Purchase Plan, as so amended, the “Purchase Plan”). Under the Purchase Plan, employees meeting certain specific employment qualifications are eligible to participate and can purchase shares of common stock semi-annually through payroll deductions at the lower of 85% of the fair market value of the stock at the commencement or end of the offering period. The purchase plan permits eligible employees to purchase shares of common stock through payroll deductions for up to 10% of qualified compensation. The Company has two offering periods in the Purchase Plan coinciding with the Company’s first two fiscal quarters and the last two fiscal quarters. Actual shares are issued on the first day of the subsequent offering period for the prior offering period payroll deductions. The number of shares issued at the beginning of the current period (as of June 30, 2013) was 31,695. As of September 28, 2013, there were 189,576 shares available for issuance under the Purchase Plan. |
Note_12_Treasury_Stock_Transac
Note 12 - Treasury Stock Transactions | 9 Months Ended |
Sep. 28, 2013 | |
Disclosure Text Block Supplement [Abstract] | ' |
Treasury Stock [Text Block] | ' |
12. Treasury Stock Transactions | |
Our Board of Directors instituted a share repurchase program in February 2010, which authorized the repurchase of up to $7.5 million of the Company’s outstanding shares of common stock at prevailing market prices, from time to time over the subsequent 12 months. In February 2011, the share repurchase program was extended through February 2013. During the thirty-nine week period ended September 28, 2013, the Company repurchased 15,450 shares for an average price of $5.35 per share. Since the inception of its share repurchase program and through September 28, 2013, the Company has purchased 1,473,306 shares at a total cost of approximately $7.5 million, or an average price of $5.09. The last repurchase occurred in January 2013 whereby the entire authorized repurchase amount of $7.5 million was expended. |
Note_13_New_Accounting_Standar
Note 13 - New Accounting Standards | 9 Months Ended |
Sep. 28, 2013 | |
Table Text Block [Abstract] | ' |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] | ' |
13. New Accounting Standards | |
There have been no recent accounting pronouncements or changes in accounting pronouncements during the thirty-nine week period ended September 28, 2013, as compared to the recent accounting pronouncements described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 29, 2012, that are of material significance, or have potential material significance, to the Company. |
Note_14_Segment_Information
Note 14 - Segment Information | 9 Months Ended | ||||||||||||||||||||
Sep. 28, 2013 | |||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||
Segment Reporting Disclosure [Text Block] | ' | ||||||||||||||||||||
14. Segment Information | |||||||||||||||||||||
The Company follows “Disclosures about Segments of an Enterprise and Related Information,” which establishes standards for companies to report information about operating segments, geographic areas and major customers. The accounting policies of each reportable segment are the same as those described in the summary of significant accounting policies (see Note 1 to the Company’s Consolidated Financial Statements included in its Annual Report on Form 10-K for the year ended December 29, 2012). | |||||||||||||||||||||
Segment operating income includes selling, general and administrative expenses directly attributable to that segment as well as charges for allocating corporate costs to each of the operating segments. The following tables reflect the results of the reportable segments consistent with the Company’s management system: | |||||||||||||||||||||
Thirteen Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
28-Sep-13 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 13,156 | $ | 22,000 | $ | 6,164 | $ | - | $ | 41,320 | |||||||||||
Cost of services | 9,649 | 16,660 | 4,327 | - | 30,636 | ||||||||||||||||
Selling, general and administrative | 3,292 | 3,410 | 1,897 | - | 8,599 | ||||||||||||||||
Depreciation and amortization | 66 | 187 | 26 | - | 279 | ||||||||||||||||
Operating income (loss) | $ | 149 | $ | 1,743 | $ | (86 | ) | $ | - | $ | 1,806 | ||||||||||
Total assets | $ | 14,106 | $ | 45,525 | $ | 12,507 | $ | 17,818 | $ | 89,956 | |||||||||||
Capital expenditures | - | $ | 226 | - | - | $ | 226 | ||||||||||||||
Thirteen Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
29-Sep-12 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 12,373 | $ | 17,142 | $ | 5,324 | $ | - | $ | 34,839 | |||||||||||
Cost of services | 8,739 | 12,845 | 3,580 | - | 25,164 | ||||||||||||||||
Selling, general and administrative | 3,323 | 3,088 | 1,742 | - | 8,153 | ||||||||||||||||
Depreciation and amortization | 89 | 298 | 28 | - | 415 | ||||||||||||||||
Operating income (loss) | $ | 222 | $ | 911 | $ | (26 | ) | $ | - | $ | 1,107 | ||||||||||
Total assets | $ | 13,944 | $ | 30,148 | $ | 9,088 | $ | 35,562 | $ | 88,742 | |||||||||||
Capital expenditures | $ | 9 | $ | 107 | $ | - | $ | 23 | $ | 139 | |||||||||||
Thirty-Nine Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
28-Sep-13 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 41,378 | $ | 63,263 | $ | 20,288 | $ | - | $ | 124,929 | |||||||||||
Cost of services | 29,706 | 48,562 | 14,094 | - | 92,362 | ||||||||||||||||
Selling, general and administrative (Includes facilities consolidation change) | 10,404 | 10,840 | 5,460 | - | 26,704 | ||||||||||||||||
Depreciation and amortization | 236 | 509 | 84 | - | 829 | ||||||||||||||||
Operating income | $ | 1,032 | $ | 3,352 | $ | 650 | $ | - | $ | 5,034 | |||||||||||
Total assets | $ | 14,106 | $ | 45,525 | $ | 12,507 | $ | 17,818 | $ | 89,956 | |||||||||||
Capital expenditures | $ | 57 | $ | 859 | $ | 4 | $ | 151 | $ | 1,071 | |||||||||||
Thirty-Nine Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
29-Sep-12 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 39,520 | $ | 48,529 | $ | 20,749 | $ | - | $ | 108,798 | |||||||||||
Cost of services | 27,945 | 37,112 | 14,125 | - | 79,182 | ||||||||||||||||
Selling, general and administrative | 10,564 | 8,659 | 5,543 | - | 24,766 | ||||||||||||||||
Depreciation and amortization | 282 | 575 | 96 | - | 953 | ||||||||||||||||
Operating income | $ | 729 | $ | 2,183 | $ | 985 | $ | - | $ | 3,897 | |||||||||||
Total assets | $ | 13,944 | $ | 30,148 | $ | 9,088 | $ | 35,562 | $ | 88,742 | |||||||||||
Capital expenditures | $ | 57 | $ | 170 | $ | - | $ | 23 | $ | 250 | |||||||||||
The Company derives a majority of its revenue from offices in the United States. Revenues reported for each operating segment are all from external customers. The Company is domiciled in the United States and its segments operate in the United States, Canada and Puerto Rico. Revenues by geographic area for the thirteen and thirty-nine week periods ended September 28, 2013 and September 29, 2012 are as follows: | |||||||||||||||||||||
Thirteen Week Periods Ended | Thirty-Nine Week Periods Ended | ||||||||||||||||||||
September 28, | September 29, | September 28, | September 29, | ||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||
Revenues | |||||||||||||||||||||
U. S. | $ | 30,991 | $ | 28,118 | $ | 96,558 | $ | 90,871 | |||||||||||||
Canada | 8,980 | 5,308 | 24,429 | 14,504 | |||||||||||||||||
Puerto Rico | 1,349 | 1,413 | 3,942 | 3,423 | |||||||||||||||||
$ | 41,320 | $ | 34,839 | $ | 124,929 | $ | 108,798 | ||||||||||||||
Total assets by geographic area as of the reported periods are as follows: | |||||||||||||||||||||
September 28, | December 29, | ||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||
Total assets | |||||||||||||||||||||
U. S. | $ | 65,363 | $ | 68,364 | |||||||||||||||||
Canada | 23,238 | 14,612 | |||||||||||||||||||
Puerto Rico | 1,355 | 1,572 | |||||||||||||||||||
$ | 89,956 | $ | 84,548 | ||||||||||||||||||
Note_15_Income_Taxes
Note 15 - Income Taxes | 9 Months Ended |
Sep. 28, 2013 | |
Income Tax Disclosure [Abstract] | ' |
Income Tax Disclosure [Text Block] | ' |
15. Income Taxes | |
The Company reduced an unrecognized tax benefit of $0.5 million during the thirty-nine week period ended September 28, 2013. Before considering this discreet adjustment, the projected fiscal 2013 effective income tax rate as of September 28, 2013 was approximately 41.3% and 28.2% in the United States and Canada, respectively, and yielded a consolidated effective income tax rate of approximately 39.3% for the thirty-nine week period ended September 28, 2013. The Company estimated income tax rates of approximately 42.9% and 26.8% in the United States and Canada, respectively, which yielded a consolidated effective income tax rate of approximately 43.9% for the thirty-nine week period ended September 29, 2012. The relative income or loss generated in each jurisdiction can materially impact the overall effective income tax rate of the company. |
Note_16_Contingencies
Note 16 - Contingencies | 9 Months Ended |
Sep. 28, 2013 | |
Loss Contingency [Abstract] | ' |
Contingencies Disclosure [Text Block] | ' |
16. Contingencies | |
From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries. The Company may not be covered by insurance as it pertains to some or all of these matters. A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter. Once established, a provision may change in the future due to new developments or changes in circumstances, and could increase or decrease the Company’s earnings in the period that the changes are made. Included in the Company’s accounts payable and accrued expenses is a provision for losses from legal matters aggregating approximately $0.1 million and $0.2 million as of September 28, 2013 and December 29, 2012, respectively. Asserted claims in these matters seek approximately $9.7 million in damages as of September 28, 2013. | |
The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which may not be covered by insurance. |
Note_17_Stockholder_Rights_Pla
Note 17 - Stockholder Rights Plan | 9 Months Ended |
Sep. 28, 2013 | |
Stockholder Right Plan [Abstract] | ' |
Stockholder Right Plan [Text Block] | ' |
17. Stockholder Rights Plan | |
On January 30, 2013, the Board of Directors of the Company approved a stockholder rights plan (the “Rights Plan”) and declared a dividend distribution to stockholders of record as of the close of business on February 10, 2013 of one preferred stock purchase right (a “Right”) for each outstanding share of Common Stock of the Company. Each Right entitles the holder to purchase from the Company a unit consisting of one one-hundredth of a share (a “Unit”) of a newly-authorized series of junior participating preferred stock of the Company, upon the occurrence of certain events, at a purchase price of $15.00 per Unit. | |
In connection with the adoption of the stockholder rights plan, the Company designated 250,000 shares of the Company’s authorized shares of Preferred Stock, par value $1.00, as Series A-2 Junior Participating Preferred Shares, none of which are issued and outstanding. As provided in the Certificate of Designation filed by the Company with the Department of State of the State of Nevada, each Series A-2 Preferred Share shall entitle the holder 100 votes on all matters submitted to a vote of the stockholders of the Corporation, subject to adjustment for future dividends and combinations of common stock. The holders of Series A-2 Preferred Shares and the holders of shares of Common Stock shall vote together as one class on all matters submitted to a vote of stockholders of the Corporation. The Series A-2 Preferred Shares shall, after issuance, be entitled to receive quarterly dividends in an amount equal to the greater of $50.00 per share or an amount per share, subject to adjustment, equal to 100 times the aggregate per share amount of all non-cash dividends or other distributions other than a dividend payable in shares of common stock or a subdivision of the outstanding shares of common stock declared on the common stock since the immediately preceding quarterly dividend payment date of the Series A-2 Preferred Shares, or, with respect to the first such quarterly dividend payment date, since the first issuance of any share or fraction of a share of the Series A-2 Preferred Shares. The Series A-2 Preferred Shares shall rank junior to all other series of the Corporation’s Preferred Stock as to the payment of dividends and the distribution of assets, unless the terms of any such series shall provide otherwise. The Series A-2 Preferred Shares shall not be redeemable. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation, the holders of Series A-2 Preferred Shares shall be entitled to receive the greater of $100.00 per share, plus accrued dividends, or an amount per share, subject to adjustment, equal to 100 times the aggregate amount to be distributed per share to holders of Common Stock. In the event the Company shall enter into any consolidation, merger, combination or other transaction in which the shares of Common Stock are exchanged for or changed into other stock or securities, cash and/or any other property, then in any such event the Series A-2 Preferred Shares shall at the same time be similarly exchanged or changed in an amount per share, subject to adjustment, equal to 100 times the aggregate amount of stock, securities, cash and/or any other property (payable in kind), as the case may be, into which or for which each share of Common Stock is changed or exchanged. These preferences are protected by customary anti-dilution provisions. | |
Initially, the Rights are not exercisable and are attached to each existing outstanding share of the Company’s Common Stock. The Rights will separate and become exercisable if a person or group acquires 15% or more of the Company’s Common Stock in a transaction, including the open market purchase of shares, not approved by our Board. If a person or group acquires 15%, each Right will entitle its holder (other than such person or members of such group) to purchase, at the Right’s exercise price (subject to adjustment as provided in the Rights Plan), a number of shares of the Company’s Common Stock having a then-current market value of twice the exercise price. The Rights Plan will cause substantial dilution to a person or group that attempts to acquire control of the Company on terms or in a manner not approved by our Board. | |
The initial issuance of the Rights as a dividend had no financial accounting or reporting impact. The fair value of the Rights was nominal because the Rights were not exercisable when issued and no value is attributable to them. Additionally, the Rights do not meet the definition of a liability under generally accepted accounting principles in the United States and are therefore not accounted for as a long-term obligation. Accordingly, unless the Rights become exercisable as discussed above, the Rights Plan has no impact on the Company’s Consolidated Financial Statements. | |
On May 28, 2013, our Board approved the amendment and restatement of the Rights Plan for the primary purpose of incorporating a stockholder redemption feature (qualifying offer clause) providing that if the Company receives a Qualifying Offer (as defined in the Rights Plan, as amended and restated) and our Board has not redeemed the outstanding Rights or exempted such offer from the terms of the Rights Plan, as amended and restated, or called a special meeting of stockholders for the purpose of voting on whether or not to exempt such Qualifying Offer from the terms of the Rights Plan, as amended and restated, in each case by the end of the ninety (90) business days following the commencement of such Qualifying Offer, the holders of 10 percent of the common stock may call a special meeting of stockholders to vote on a resolution authorizing the redemption of all, but not less than all, of the then outstanding Rights at the Redemption Price (as defined in the Rights Plan, as amended and restated). | |
The Rights Plan is not intended to interfere with any merger, tender or exchange offer or other business combination approved by our Board. Nor does the Rights Plan prevent our Board from considering any offer that it considers to be in the best interest of its stockholders. |
Note_18_Facilities_Consolidati
Note 18 - Facilities Consolidation Charge | 9 Months Ended |
Sep. 28, 2013 | |
Accounting Policies [Abstract] | ' |
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] | ' |
18. Facilities Consolidation Charge | |
In early fiscal 2013 the Company’s Canadian operations elected to consolidate its Mississauga location into its expanded Pickering location. In addition to customary moving expenses the Company incurred severance costs as several employees elected to receive statutory mandated severance payments as opposed to relocating their place of work. The Company incurred $0.3 million in costs related to the office consolidation for the thirty-nine weeks ended September 28, 2013 which primarily consisted of severance and other related costs. |
Note_4_Accounts_Receivable_Tab
Note 4 - Accounts Receivable (Tables) | 9 Months Ended | ||||||||
Sep. 28, 2013 | |||||||||
Receivables [Abstract] | ' | ||||||||
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | ' | ||||||||
September 28, | December 29, | ||||||||
2013 | 2012 | ||||||||
Billed | $ | 36,131 | $ | 26,600 | |||||
Accrued and unbilled | 5,839 | 4,761 | |||||||
Work-in-progress | 13,836 | 13,552 | |||||||
Allowance for doubtful accounts and sales discounts | (978 | ) | (1,207 | ) | |||||
Accounts receivable, net | $ | 54,828 | $ | 43,706 |
Note_5_Property_and_Equipment_
Note 5 - Property and Equipment (Tables) | 9 Months Ended | ||||||||
Sep. 28, 2013 | |||||||||
Property, Plant and Equipment [Abstract] | ' | ||||||||
Property, Plant and Equipment [Table Text Block] | ' | ||||||||
September 28, | December 29, | ||||||||
2013 | 2012 | ||||||||
Equipment and furniture | $ | 2,380 | $ | 2,366 | |||||
Computers and systems | 5,582 | 5,204 | |||||||
Leasehold improvements | 480 | 949 | |||||||
8,442 | 8,519 | ||||||||
Less: accumulated depreciation and amortization | 6,223 | 6,639 | |||||||
Property and equipment, net | $ | 2,219 | $ | 1,880 |
Note_6_Acquisitions_Tables
Note 6 - Acquisitions (Tables) | 9 Months Ended | ||||
Sep. 28, 2013 | |||||
Business Combinations [Abstract] | ' | ||||
Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] | ' | ||||
Period Ending | |||||
28-Dec-13 | $ | 313 | |||
3-Jan-15 | 253 | ||||
2-Jan-16 | 269 | ||||
31-Dec-16 | 307 | ||||
Estimated future contingent consideration payments | $ | 1,142 | |||
Schedule of Business Acquisitions, by Acquisition [Table Text Block] | ' | ||||
Cash | $ | 1,292 | |||
Lease in excess of market, at fair value | 469 | ||||
Contingent consideration, at fair value | 930 | ||||
Total consideration | $ | 2,691 | |||
Fixed assets | $ | 28 | |||
Restricted covenants | 70 | ||||
Customer relationships | 180 | ||||
Deferred tax asset | 187 | ||||
Goodwill | 2,226 | ||||
Total consideration | $ | 2,691 | |||
Business Acquisition, Pro Forma Information [Table Text Block] | ' | ||||
Proforma Results | |||||
for the Thirty-Nine | |||||
Week Period Ended | |||||
29-Sep-12 | |||||
Revenues | $ | 111,401 | |||
Operating income | 4,032 | ||||
Basic and diluted earnings per share | $ | 0.18 |
Note_8_Intangible_Assets_Table
Note 8 - Intangible Assets (Tables) | 9 Months Ended | ||||||||||||
Sep. 28, 2013 | |||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||
Schedule of Finite-Lived Intangible Assets [Table Text Block] | ' | ||||||||||||
Information Technology | Engineering | Total | |||||||||||
Balance as of December 29, 2012 | $ | 106 | $ | 226 | $ | 332 | |||||||
Amortization of intangibles during the thirty-nine week period ended September 28, 2013 | 60 | 36 | 96 | ||||||||||
Balance as of September 28, 2013 | $ | 46 | $ | 190 | $ | 236 |
Note_10_Per_Share_Data_Tables
Note 10 - Per Share Data (Tables) | 9 Months Ended | ||||||||||||||||
Sep. 28, 2013 | |||||||||||||||||
Earnings Per Share [Abstract] | ' | ||||||||||||||||
Schedule of Weighted Average Number of Shares [Table Text Block] | ' | ||||||||||||||||
Thirteen Week Periods Ended | Thirty-Nine Week Periods Ended | ||||||||||||||||
September 28, | September 29, | September 28, | September 29, | ||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||
Basic weighted average shares outstanding | 12,364,018 | 12,057,478 | 12,333,318 | 12,422,558 | |||||||||||||
Dilutive effect of outstanding stock options | 123,400 | 194,731 | 98,143 | 205,140 | |||||||||||||
Weighted average dilutive shares outstanding | 12,487,418 | 12,252,209 | 12,431,461 | 12,627,698 | |||||||||||||
Unissued Shares of Common Stock [Table Text Block] | ' | ||||||||||||||||
September 28, | December 29, | ||||||||||||||||
2013 | 2012 | ||||||||||||||||
Exercise of options outstanding | 279,900 | 307,400 | |||||||||||||||
Restricted stock awards outstanding | 327,500 | 350,000 | |||||||||||||||
Future grants of options or shares | 56,600 | 34,100 | |||||||||||||||
Shares reserved for employee stock purchase plan | 189,576 | 247,752 | |||||||||||||||
Total | 853,576 | 939,252 |
Note_11_Share_Based_Compensati1
Note 11 - Share Based Compensation (Tables) | 9 Months Ended | |||||||||
Sep. 28, 2013 | ||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ' | |||||||||
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] | ' | |||||||||
All Stock Options Outstanding | ||||||||||
Shares | Weighted Average | |||||||||
Exercise Price | ||||||||||
Options outstanding as of December 29, 2012 | 307,400 | $ | 5.34 | |||||||
Options granted | 5,000 | $ | 5.78 | |||||||
Options exercised | -24,500 | $ | 4.01 | |||||||
Options forfeited/cancelled | -8,000 | $ | 5.16 | |||||||
Options outstanding as of September 28, 2013 | 279,900 | $ | 5.47 | |||||||
Options outstanding price range at September 28, 2013 | $2.50 | - | $9.81 | |||||||
Options exercisable as of September 28, 2013 | 224,900 | $ | 5.44 | |||||||
Intrinsic value of outstanding stock options as of September 28, 2013 | $290 | |||||||||
Intrinsic value of stock options exercised for the thirty-nine week period ended September 28, 2013 | $40 | |||||||||
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] | ' | |||||||||
Number of | Weighted | |||||||||
Restricted | Average | |||||||||
Stock Units | Grant Date Fair | |||||||||
(in thousands) | Value per Share | |||||||||
Outstanding non-vested at December 29, 2012 | 350 | $ | 5.62 | |||||||
Granted | 8 | $ | 5.45 | |||||||
Vested | - | N/A | ||||||||
Forfeited or expired | (30 | ) | $ | 5.62 | ||||||
Outstanding non-vested at September 28, 2013 | 328 | $ | 5.62 |
Note_14_Segment_Information_Ta
Note 14 - Segment Information (Tables) | 9 Months Ended | ||||||||||||||||||||
Sep. 28, 2013 | |||||||||||||||||||||
Segment Reporting [Abstract] | ' | ||||||||||||||||||||
Schedule of Segment Reporting Information, by Segment [Table Text Block] | ' | ||||||||||||||||||||
Thirteen Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
28-Sep-13 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 13,156 | $ | 22,000 | $ | 6,164 | $ | - | $ | 41,320 | |||||||||||
Cost of services | 9,649 | 16,660 | 4,327 | - | 30,636 | ||||||||||||||||
Selling, general and administrative | 3,292 | 3,410 | 1,897 | - | 8,599 | ||||||||||||||||
Depreciation and amortization | 66 | 187 | 26 | - | 279 | ||||||||||||||||
Operating income (loss) | $ | 149 | $ | 1,743 | $ | (86 | ) | $ | - | $ | 1,806 | ||||||||||
Total assets | $ | 14,106 | $ | 45,525 | $ | 12,507 | $ | 17,818 | $ | 89,956 | |||||||||||
Capital expenditures | - | $ | 226 | - | - | $ | 226 | ||||||||||||||
Thirteen Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
29-Sep-12 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 12,373 | $ | 17,142 | $ | 5,324 | $ | - | $ | 34,839 | |||||||||||
Cost of services | 8,739 | 12,845 | 3,580 | - | 25,164 | ||||||||||||||||
Selling, general and administrative | 3,323 | 3,088 | 1,742 | - | 8,153 | ||||||||||||||||
Depreciation and amortization | 89 | 298 | 28 | - | 415 | ||||||||||||||||
Operating income (loss) | $ | 222 | $ | 911 | $ | (26 | ) | $ | - | $ | 1,107 | ||||||||||
Total assets | $ | 13,944 | $ | 30,148 | $ | 9,088 | $ | 35,562 | $ | 88,742 | |||||||||||
Capital expenditures | $ | 9 | $ | 107 | $ | - | $ | 23 | $ | 139 | |||||||||||
Thirty-Nine Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
28-Sep-13 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 41,378 | $ | 63,263 | $ | 20,288 | $ | - | $ | 124,929 | |||||||||||
Cost of services | 29,706 | 48,562 | 14,094 | - | 92,362 | ||||||||||||||||
Selling, general and administrative (Includes facilities consolidation change) | 10,404 | 10,840 | 5,460 | - | 26,704 | ||||||||||||||||
Depreciation and amortization | 236 | 509 | 84 | - | 829 | ||||||||||||||||
Operating income | $ | 1,032 | $ | 3,352 | $ | 650 | $ | - | $ | 5,034 | |||||||||||
Total assets | $ | 14,106 | $ | 45,525 | $ | 12,507 | $ | 17,818 | $ | 89,956 | |||||||||||
Capital expenditures | $ | 57 | $ | 859 | $ | 4 | $ | 151 | $ | 1,071 | |||||||||||
Thirty-Nine Week Period Ended | Information | Engineering | Specialty | Corporate | Total | ||||||||||||||||
29-Sep-12 | Technology | Health Care | |||||||||||||||||||
Revenue | $ | 39,520 | $ | 48,529 | $ | 20,749 | $ | - | $ | 108,798 | |||||||||||
Cost of services | 27,945 | 37,112 | 14,125 | - | 79,182 | ||||||||||||||||
Selling, general and administrative | 10,564 | 8,659 | 5,543 | - | 24,766 | ||||||||||||||||
Depreciation and amortization | 282 | 575 | 96 | - | 953 | ||||||||||||||||
Operating income | $ | 729 | $ | 2,183 | $ | 985 | $ | - | $ | 3,897 | |||||||||||
Total assets | $ | 13,944 | $ | 30,148 | $ | 9,088 | $ | 35,562 | $ | 88,742 | |||||||||||
Capital expenditures | $ | 57 | $ | 170 | $ | - | $ | 23 | $ | 250 | |||||||||||
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] | ' | ||||||||||||||||||||
Thirteen Week Periods Ended | Thirty-Nine Week Periods Ended | ||||||||||||||||||||
September 28, | September 29, | September 28, | September 29, | ||||||||||||||||||
2013 | 2012 | 2013 | 2012 | ||||||||||||||||||
Revenues | |||||||||||||||||||||
U. S. | $ | 30,991 | $ | 28,118 | $ | 96,558 | $ | 90,871 | |||||||||||||
Canada | 8,980 | 5,308 | 24,429 | 14,504 | |||||||||||||||||
Puerto Rico | 1,349 | 1,413 | 3,942 | 3,423 | |||||||||||||||||
$ | 41,320 | $ | 34,839 | $ | 124,929 | $ | 108,798 | ||||||||||||||
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block] | ' | ||||||||||||||||||||
September 28, | December 29, | ||||||||||||||||||||
2013 | 2012 | ||||||||||||||||||||
Total assets | |||||||||||||||||||||
U. S. | $ | 65,363 | $ | 68,364 | |||||||||||||||||
Canada | 23,238 | 14,612 | |||||||||||||||||||
Puerto Rico | 1,355 | 1,572 | |||||||||||||||||||
$ | 89,956 | $ | 84,548 |
Note_4_Accounts_Receivable_Det
Note 4 - Accounts Receivable (Details) - Accounts Receivable (USD $) | Sep. 28, 2013 | Dec. 29, 2012 |
In Thousands, unless otherwise specified | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' |
Allowance for doubtful accounts and sales discounts | ($978) | ($1,207) |
Accounts receivable, net | 54,828 | 43,706 |
Billed Revenues [Member] | ' | ' |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' |
Accounts receivable, current | 36,131 | 26,600 |
Unbilled Revenues [Member] | ' | ' |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' |
Accounts receivable, current | 5,839 | 4,761 |
Work In Progress [Member] | ' | ' |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ' | ' |
Accounts receivable, current | $13,836 | $13,552 |
Note_5_Property_and_Equipment_1
Note 5 - Property and Equipment (Details) (USD $) | 9 Months Ended | |
Sep. 28, 2013 | Sep. 29, 2012 | |
Property, Plant and Equipment [Abstract] | ' | ' |
Annual Depreciation Rate | 20.00% | ' |
Write Off of Fully Depreciated Property and Equipment | $1,149 | $1,466 |
Note_5_Property_and_Equipment_2
Note 5 - Property and Equipment (Details) - Property and Equipment (USD $) | Sep. 28, 2013 | Dec. 29, 2012 |
In Thousands, unless otherwise specified | ||
Property, Plant and Equipment [Line Items] | ' | ' |
Property plant and equipment gross | $8,442 | $8,519 |
Less: accumulated depreciation and amortization | 6,223 | 6,639 |
Property and equipment, net | 2,219 | 1,880 |
Equipment and Furniture [Member] | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Property plant and equipment gross | 2,380 | 2,366 |
Computers and Systems [Member] | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Property plant and equipment gross | 5,582 | 5,204 |
Leasehold Improvements [Member] | ' | ' |
Property, Plant and Equipment [Line Items] | ' | ' |
Property plant and equipment gross | $480 | $949 |
Note_6_Acquisitions_Details
Note 6 - Acquisitions (Details) (USD $) | 9 Months Ended | ||||||
In Thousands, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 | Dec. 31, 2016 | Jan. 02, 2016 | Jan. 03, 2015 | Dec. 28, 2013 | Sep. 28, 2013 |
BGA [Member] | BGA [Member] | BGA [Member] | BGA [Member] | Maximum [Member] | |||
BGA [Member] | |||||||
Note 6 - Acquisitions (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Business Combination, Contingent Consideration, Liability | ' | ' | $307 | $269 | $253 | $313 | $3,000 |
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | ($92) | ($43) | ' | ' | ' | ' | ' |
Note_6_Acquisitions_Details_Ma
Note 6 - Acquisitions (Details) - Maximum Deferred Consideratoin Payments (BGA [Member], USD $) | Sep. 28, 2013 | Dec. 31, 2016 | Jan. 02, 2016 | Jan. 03, 2015 | Dec. 28, 2013 |
In Thousands, unless otherwise specified | Estimated Future Payments [Member] | ||||
Business Acquisition, Contingent Consideration [Line Items] | ' | ' | ' | ' | ' |
Estimated contingent consideration payments | $1,142 | $307 | $269 | $253 | $313 |
Note_6_Acquisitions_Details_BG
Note 6 - Acquisitions (Details) - BGA Purchase Consideration (USD $) | 9 Months Ended | 9 Months Ended | ||||
In Thousands, unless otherwise specified | Sep. 29, 2012 | Sep. 28, 2013 | Dec. 29, 2012 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 |
BGA [Member] | BGA [Member] | BGA [Member] | ||||
Restricted Covenants [Member] | Customer Relationships [Member] | |||||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' | ' |
Cash | $1,292 | ' | ' | ' | ' | $1,292 |
Lease in excess of market, at fair value | ' | ' | ' | ' | ' | 469 |
Contingent consideration, at fair value | ' | ' | ' | ' | ' | 930 |
Total consideration | ' | ' | ' | ' | ' | 2,691 |
Fixed assets | ' | ' | ' | ' | ' | 28 |
Intangible assets acquired | ' | ' | ' | 70 | 180 | ' |
Deferred tax asset | ' | ' | ' | ' | ' | 187 |
Goodwill | ' | $9,545 | $9,545 | ' | ' | $2,226 |
Note_6_Acquisitions_Details_Bu
Note 6 - Acquisitions (Details) - Business Acquisition, Pro Forma Information (Pro Forma [Member], USD $) | 9 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Sep. 29, 2012 |
Pro Forma [Member] | ' |
Note 6 - Acquisitions (Details) - Business Acquisition, Pro Forma Information [Line Items] | ' |
Revenues | $111,401 |
Operating income | $4,032 |
Basic and diluted earnings per share (in Dollars per share) | $0.18 |
Note_7_Goodwill_Details
Note 7 - Goodwill (Details) (USD $) | Sep. 28, 2013 | Dec. 29, 2012 |
In Thousands, unless otherwise specified | ||
Note 7 - Goodwill (Details) [Line Items] | ' | ' |
Goodwill | $9,545 | $9,545 |
Information Technology [Member] | ' | ' |
Note 7 - Goodwill (Details) [Line Items] | ' | ' |
Goodwill | 5,516 | 5,516 |
Engineering [Member] | ' | ' |
Note 7 - Goodwill (Details) [Line Items] | ' | ' |
Goodwill | 2,326 | 2,326 |
Specialty Health Care [Member] | ' | ' |
Note 7 - Goodwill (Details) [Line Items] | ' | ' |
Goodwill | $1,703 | $1,703 |
Note_8_Intangible_Assets_Detai
Note 8 - Intangible Assets (Details) (USD $) | 9 Months Ended | |
Sep. 28, 2013 | Sep. 29, 2012 | |
Disclosure Text Block [Abstract] | ' | ' |
Impairment of Intangible Assets, Finite-lived | $0 | $171,000 |
Note_8_Intangible_Assets_Detai1
Note 8 - Intangible Assets (Details) - Components of Intangible Assets (USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Sep. 28, 2013 |
Finite-Lived Intangible Assets [Line Items] | ' |
Balance as of December 29, 2012 | $332 |
Amortization of intangibles during the thirty-nine week period ended September 28, 2013 | 96 |
Balance as of September 28, 2013 | 236 |
Information Technology [Member] | ' |
Finite-Lived Intangible Assets [Line Items] | ' |
Balance as of December 29, 2012 | 106 |
Amortization of intangibles during the thirty-nine week period ended September 28, 2013 | 60 |
Balance as of September 28, 2013 | 46 |
Engineering [Member] | ' |
Finite-Lived Intangible Assets [Line Items] | ' |
Balance as of December 29, 2012 | 226 |
Amortization of intangibles during the thirty-nine week period ended September 28, 2013 | 36 |
Balance as of September 28, 2013 | $190 |
Note_9_Line_of_Credit_Details
Note 9 - Line of Credit (Details) (USD $) | Dec. 29, 2012 | Sep. 28, 2012 | Sep. 28, 2013 | Sep. 29, 2012 | Feb. 20, 2009 | Feb. 20, 2009 |
Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Revolving Credit Facility [Member] | Letter of Credit [Member] | |||
Note 9 - Line of Credit (Details) [Line Items] | ' | ' | ' | ' | ' | ' |
Line of Credit Facility, Maximum Borrowing Capacity | ' | ' | ' | ' | $15,000,000 | $5,000,000 |
Line of Credit Facility, Amount Outstanding | ' | ' | 0 | 0 | ' | ' |
Letters of Credit Outstanding, Amount | 800,000 | 800,000 | ' | ' | ' | ' |
Line of Credit Facility, Remaining Borrowing Capacity | ' | ' | $14,200,000 | ' | ' | ' |
Note_10_Per_Share_Data_Details
Note 10 - Per Share Data (Details) | 9 Months Ended | |
Sep. 28, 2013 | Sep. 29, 2012 | |
Earnings Per Share [Abstract] | ' | ' |
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 97,500 | 62,500 |
Note_10_Per_Share_Data_Details1
Note 10 - Per Share Data (Details) - Weighted Average Number of Common Shares | 3 Months Ended | 9 Months Ended | ||
Sep. 28, 2013 | Sep. 29, 2012 | Sep. 28, 2013 | Sep. 29, 2012 | |
Weighted Average Number of Common Shares [Abstract] | ' | ' | ' | ' |
Basic weighted average shares outstanding | 12,364,018 | 12,057,478 | 12,333,318 | 12,422,558 |
Dilutive effect of outstanding stock options | 123,400 | 194,731 | 98,143 | 205,140 |
Weighted average dilutive shares outstanding | 12,487,418 | 12,252,209 | 12,431,461 | 12,627,698 |
Note_10_Per_Share_Data_Details2
Note 10 - Per Share Data (Details) - Unissued Shares of Common Stock Were Reserved For The Following Purposes | Sep. 28, 2013 | Dec. 29, 2012 |
Unissued Shares of Common Stock Were Reserved For The Following Purposes [Abstract] | ' | ' |
Exercise of options outstanding | 279,900 | 307,400 |
Restricted stock awards outstanding | 327,500 | 350,000 |
Future grants of options or shares | 56,600 | 34,100 |
Shares reserved for employee stock purchase plan | 189,576 | 247,752 |
Total | 853,576 | 939,252 |
Note_11_Share_Based_Compensati2
Note 11 - Share Based Compensation (Details) (USD $) | 0 Months Ended | 9 Months Ended | 9 Months Ended | 0 Months Ended | 9 Months Ended | 9 Months Ended | |||||||||||
Jul. 01, 2013 | Sep. 28, 2013 | Sep. 29, 2012 | Dec. 29, 2012 | Sep. 28, 2013 | Sep. 29, 2012 | Nov. 16, 2012 | Sep. 28, 2013 | Dec. 29, 2012 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | Sep. 28, 2013 | |
Employee Stock Option [Member] | Employee Stock Option [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | Restricted Stock Units (RSUs) [Member] | The 1996 Plan [Member] | The 2000 Plan [Member] | The 2007 Plan [Member] | Maximum Shares Issued Pursuant to Stock-based Awards [Member] | Maximum Shares That May Be Granted to Any Individual [Member] | ESPP [Member] | Minimum [Member] | Maximum [Member] | |||||
Note 11 - Share Based Compensation (Details) [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '1 year | '3 years |
Share Based Compensation Expiration Period of Stock Options | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation (in Dollars) | ' | $515,000 | $60,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars) | ' | 1,200,000 | ' | ' | 100,000 | ' | ' | 1,100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition | ' | '3 years | ' | ' | '3 years | ' | ' | '25 months 15 days | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,250,000 | 1,500,000 | 700,000 | 350,000 | 300,000 | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | ' | 279,900 | ' | 307,400 | ' | ' | ' | ' | ' | 132,000 | 71,500 | 76,400 | ' | ' | ' | 2.5 | 9.81 |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 56,600 | ' | ' | 189,576 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | ' | ' | ' | ' | ' | ' | ' | 328,000 | 350,000 | ' | ' | 327,500 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | ' | ' | ' | ' | 5,000 | 20,000 | 350,000 | 8,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share Price (in Dollars per share) | ' | $6.04 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value (in Dollars) | ' | ' | ' | ' | ' | ' | ' | $2,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Stock Issued During Period, Shares, Employee Stock Purchase Plans | 31,695 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Note_11_Share_Based_Compensati3
Note 11 - Share Based Compensation (Details) - Transactions Related to All Stock Options (USD $) | 9 Months Ended |
In Thousands, except Share data, unless otherwise specified | Sep. 28, 2013 |
Note 11 - Share Based Compensation (Details) - Transactions Related to All Stock Options [Line Items] | ' |
Options outstanding | 307,400 |
Options outstanding weighted average exercise price (in Dollars per share) | $5.34 |
Options exercisable as of September 28, 2013 | 224,900 |
Options exercisable as of September 28, 2013 (in Dollars per share) | $5.44 |
Intrinsic value of outstanding stock options as of September 28, 2013 (in Dollars) | $290 |
Intrinsic value of stock options exercised for the thirty-nine week period ended September 28, 2013 (in Dollars per share) | $40 |
Options granted | 5,000 |
Options granted (in Dollars per share) | $5.78 |
Options exercised | -24,500 |
Options exercised (in Dollars per share) | $4.01 |
Options forfeited/cancelled | -8,000 |
Options forfeited/cancelled (in Dollars per share) | $5.16 |
Options outstanding | 279,900 |
Options outstanding weighted average exercise price (in Dollars per share) | $5.47 |
Minimum [Member] | ' |
Note 11 - Share Based Compensation (Details) - Transactions Related to All Stock Options [Line Items] | ' |
Options outstanding | 2.5 |
Maximum [Member] | ' |
Note 11 - Share Based Compensation (Details) - Transactions Related to All Stock Options [Line Items] | ' |
Options outstanding | 9.81 |
Note_11_Share_Based_Compensati4
Note 11 - Share Based Compensation (Details) - Restricted Stock Units Activity (Restricted Stock Units (RSUs) [Member], USD $) | 0 Months Ended | 9 Months Ended |
Nov. 16, 2012 | Sep. 28, 2013 | |
Restricted Stock Units (RSUs) [Member] | ' | ' |
Note 11 - Share Based Compensation (Details) - Restricted Stock Units Activity [Line Items] | ' | ' |
Shares (in Shares) | ' | 350,000 |
Weighted Average Grant Date Fair Value | ' | $5.62 |
Granted (in Shares) | 350,000 | 8,000 |
Granted | ' | $5.45 |
Vested | ' | ' |
Forfeited or expired (in Shares) | ' | -30,000 |
Forfeited or expired | ' | $5.62 |
Shares (in Shares) | ' | 328,000 |
Weighted Average Grant Date Fair Value | ' | $5.62 |
Note_12_Treasury_Stock_Transac1
Note 12 - Treasury Stock Transactions (Details) (USD $) | 1 Months Ended | 9 Months Ended | 57 Months Ended |
Feb. 28, 2010 | Sep. 28, 2013 | Sep. 28, 2013 | |
Note 12 - Treasury Stock Transactions (Details) [Line Items] | ' | ' | ' |
Stock Repurchase Program, Authorized Amount | $7,500,000 | ' | ' |
Stock Repurchased During Period, Value | ' | -83,000 | 7,500,000 |
Treasury Stock Acquired, Average Cost Per Share (in Dollars per share) | ' | ' | $5.09 |
Stock Repurchased During Period, Shares (in Shares) | ' | ' | 1,473,306 |
Stock Repurchase Program [Member] | ' | ' | ' |
Note 12 - Treasury Stock Transactions (Details) [Line Items] | ' | ' | ' |
Stock Repurchased During Period, Value | ' | $15,450 | ' |
Treasury Stock Acquired, Average Cost Per Share (in Dollars per share) | ' | $5.35 | ' |
Note_14_Segment_Information_De
Note 14 - Segment Information (Details) - Results of the Segments (USD $) | 3 Months Ended | 9 Months Ended | |||
In Thousands, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 | Sep. 28, 2013 | Sep. 29, 2012 | Dec. 29, 2012 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Revenue | $41,320 | $34,839 | $124,929 | $108,798 | ' |
Cost of services | 30,636 | 25,164 | 92,362 | 79,182 | ' |
Selling, general and administrative | 8,599 | 8,153 | 26,361 | 24,766 | ' |
Depreciation and amortization | 279 | 415 | 829 | 953 | ' |
Operating income (loss) | 1,806 | 1,107 | 5,034 | 3,897 | ' |
Total assets | 89,956 | 88,742 | 89,956 | 88,742 | 84,548 |
Capital expenditures | 226 | 139 | 1,071 | 250 | ' |
Includes Facilities Consolidation Change [Member] | Information Technology [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Selling, general and administrative | 3,292 | ' | 10,404 | ' | ' |
Includes Facilities Consolidation Change [Member] | Engineering [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Selling, general and administrative | 3,410 | ' | 10,840 | ' | ' |
Includes Facilities Consolidation Change [Member] | Specialty Health Care [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Selling, general and administrative | 1,897 | ' | 5,460 | ' | ' |
Includes Facilities Consolidation Change [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Selling, general and administrative | 8,599 | ' | 26,704 | ' | ' |
Information Technology [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Revenue | 13,156 | 12,373 | 41,378 | 39,520 | ' |
Cost of services | 9,649 | 8,739 | 29,706 | 27,945 | ' |
Selling, general and administrative | ' | 3,323 | ' | 10,564 | ' |
Depreciation and amortization | 66 | 89 | 236 | 282 | ' |
Operating income (loss) | 149 | 222 | 1,032 | 729 | ' |
Total assets | 14,106 | 13,944 | 14,106 | 13,944 | ' |
Capital expenditures | ' | 9 | 57 | 57 | ' |
Engineering [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Revenue | 22,000 | 17,142 | 63,263 | 48,529 | ' |
Cost of services | 16,660 | 12,845 | 48,562 | 37,112 | ' |
Selling, general and administrative | ' | 3,088 | ' | 8,659 | ' |
Depreciation and amortization | 187 | 298 | 509 | 575 | ' |
Operating income (loss) | 1,743 | 911 | 3,352 | 2,183 | ' |
Total assets | 45,525 | 30,148 | 45,525 | 30,148 | ' |
Capital expenditures | 226 | 107 | 859 | 170 | ' |
Specialty Health Care [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Revenue | 6,164 | 5,324 | 20,288 | 20,749 | ' |
Cost of services | 4,327 | 3,580 | 14,094 | 14,125 | ' |
Selling, general and administrative | ' | 1,742 | ' | 5,543 | ' |
Depreciation and amortization | 26 | 28 | 84 | 96 | ' |
Operating income (loss) | -86 | -26 | 650 | 985 | ' |
Total assets | 12,507 | 9,088 | 12,507 | 9,088 | ' |
Capital expenditures | ' | ' | 4 | ' | ' |
Corporate Segment [Member] | ' | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' | ' |
Total assets | 17,818 | 35,562 | 17,818 | 35,562 | ' |
Capital expenditures | ' | $23 | $151 | $23 | ' |
Note_14_Segment_Information_De1
Note 14 - Segment Information (Details) - Revenues and Total Assets by Geographic Area (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 | Sep. 28, 2013 | Sep. 29, 2012 |
Revenues | ' | ' | ' | ' |
Revenues | $41,320 | $34,839 | $124,929 | $108,798 |
United States [Member] | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' |
Revenues | 30,991 | 28,118 | 96,558 | 90,871 |
Canada [Member] | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' |
Revenues | 8,980 | 5,308 | 24,429 | 14,504 |
Puerto Rico [Member] | ' | ' | ' | ' |
Revenues | ' | ' | ' | ' |
Revenues | $1,349 | $1,413 | $3,942 | $3,423 |
Note_14_Segment_Information_De2
Note 14 - Segment Information (Details) - Total Assets by Geographic Area (USD $) | Sep. 28, 2013 | Dec. 29, 2012 | Sep. 29, 2012 |
In Thousands, unless otherwise specified | |||
Total assets | ' | ' | ' |
Total Assets | $89,956 | $84,548 | $88,742 |
United States [Member] | ' | ' | ' |
Total assets | ' | ' | ' |
Total Assets | 65,363 | 68,364 | ' |
Canada [Member] | ' | ' | ' |
Total assets | ' | ' | ' |
Total Assets | 23,238 | 14,612 | ' |
Puerto Rico [Member] | ' | ' | ' |
Total assets | ' | ' | ' |
Total Assets | $1,355 | $1,572 | ' |
Note_15_Income_Taxes_Details
Note 15 - Income Taxes (Details) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 28, 2013 | Sep. 29, 2012 |
Note 15 - Income Taxes (Details) [Line Items] | ' | ' |
Unrecognized Tax Benefits (in Dollars) | $0.50 | ' |
Effective Income Tax Rate Reconciliation, Percent | 39.30% | 43.90% |
United States [Member] | ' | ' |
Note 15 - Income Taxes (Details) [Line Items] | ' | ' |
Effective Income Tax Rate Reconciliation, Percent | 41.30% | 42.90% |
Canada [Member] | ' | ' |
Note 15 - Income Taxes (Details) [Line Items] | ' | ' |
Effective Income Tax Rate Reconciliation, Percent | 28.20% | 26.80% |
Note_16_Contingencies_Details
Note 16 - Contingencies (Details) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 28, 2013 | Dec. 29, 2012 |
Loss Contingency [Abstract] | ' | ' |
Loss Contingency Accrual | $0.10 | $0.20 |
Loss Contingency, Damages Sought, Value | $9.70 | ' |
Note_17_Stockholder_Rights_Pla1
Note 17 - Stockholder Rights Plan (Details) (USD $) | Sep. 28, 2013 | Jan. 30, 2013 | Dec. 29, 2012 | Sep. 28, 2013 | Jan. 30, 2013 |
Series A-2 Preferred Shares [Member] | Series A-2 Preferred Shares [Member] | ||||
Note 17 - Stockholder Rights Plan (Details) [Line Items] | ' | ' | ' | ' | ' |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item) | ' | 15 | ' | ' | ' |
Preferred Stock, Shares Authorized (in Shares) | 5,000,000 | ' | 5,000,000 | ' | 250,000 |
Preferred Stock, Par or Stated Value Per Share | $1 | ' | $1 | ' | $1 |
Preferred Stock, Voting Rights | ' | ' | ' | '100 | ' |
Preferred Stock, Liquidation Preference Per Share | ' | ' | ' | $100 | ' |
Note_18_Facilities_Consolidati1
Note 18 - Facilities Consolidation Charge (Details) (USD $) | 9 Months Ended |
In Millions, unless otherwise specified | Sep. 28, 2013 |
Accounting Policies [Abstract] | ' |
Severance Costs | $0.30 |